Medicine and Dentistry
Transitional Cell Carcinoma
100%
Catenin
100%
Antineoplastic Activity
100%
Mammalian Target of Rapamycin
100%
Cyproheptadine
100%
Signal Transduction
100%
Therapeutic Agent
22%
Programmed Cell Death
22%
Cell Cycle Arrest
22%
Therapy Effect
11%
In Vitro
11%
Malignant Neoplasm
11%
Necrosis
11%
G1 Phase
11%
Xenograft
11%
P21
11%
Carcinoma Cell Line
11%
Oncogene C Myc
11%
Serotonin Antagonist
11%
Poly ADP Ribose Polymerase
11%
Biochemistry, Genetics and Molecular Biology
Signal Transduction
100%
Antineoplastic Activity
100%
Mammalian Target of Rapamycin
100%
Cyproheptadine
100%
Catenin
100%
Cell Cycle Arrest
22%
P21
11%
Oncogene C Myc
11%
G1 Phase
11%
TSC2
11%
ANGPTL4
11%
Poly ADP Ribose Polymerase
11%
Serotonin Antagonist
11%
Immunology and Microbiology
Carcinoma Cell
100%
Antineoplastic Activity
100%
Signal Transduction
100%
Catenin
100%
Cyproheptadine
100%
Cell Cycle Arrest
22%
Xenograft
11%
Oncogene C Myc
11%
Cell Cycle G1 Phase
11%
Carcinoma Cell Line
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antitumor Activity
100%
Catenin
100%
Transitional Cell Carcinoma
100%
Cyproheptadine
100%
Therapeutic Effect
11%
Malignant Neoplasm
11%
Necrosis
11%
Serotonin Antagonist
11%